SLC Transporters: Structure, Function, and Drug Discovery.
about
Structure activity relationships of benzylproline-derived inhibitors of the glutamine transporter ASCT2.Rosetta Broker for membrane protein structure prediction: concentrative nucleoside transporter 3 and corticotropin-releasing factor receptor 1 test cases.Modulation of LAT1 (SLC7A5) transporter activity and stability by membrane cholesterol.Characteristics of 29 novel atypical solute carriers of major facilitator superfamily type: evolutionary conservation, predicted structure and neuronal co-expression.Identification of SLC20A1 and SLC15A4 among other genes as potential risk factors for combined pituitary hormone deficiency.Chemical Modulation of the Human Oligopeptide Transporter 1, hPepT1.Substrate Specificity of the FurE Transporter Is Determined by Cytoplasmic Terminal Domain Interactions.Solute carrier transporters: potential targets for digestive system neoplasms.Resculpting the binding pocket of APC superfamily LeuT-fold amino acid transporters.GeneGini: Assessment via the Gini Coefficient of Reference "Housekeeping" Genes and Diverse Human Transporter Expression Profiles.CryoEM structure of the human SLC4A4 sodium-coupled acid-base transporter NBCe1.Effects of Mutations and Ligands on the Thermostability of the l-Arginine/Agmatine Antiporter AdiC and Deduced Insights into Ligand-Binding of Human l-Type Amino Acid Transporters.Ligand Screening Systems for Human Glucose Transporters as Tools in Drug Discovery.Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors.Free Energy Landscape of the Complete Transport Cycle in a Key Bacterial TransporterDirect protein-lipid interactions shape the conformational landscape of secondary transportersDescription of LAT1 Transport Mechanism at an Atomistic Level
P2860
Q37717638-0B7DB33C-A0C3-4AB1-806B-F83F3CA89617Q38642901-82F83699-8F52-4D64-BC7D-B6195A34D8BCQ38921284-C5250FDC-EB6D-4879-9CDF-F8BC622FDC89Q41981224-AB442D0C-E05D-403B-8220-598577262F3CQ47271583-012CA572-1121-4817-965F-178DC3658B65Q47431439-748EE99A-2BB5-4BDD-9E20-10C604768975Q47696716-9D45AEB8-B91A-4A2B-9578-97F6BBAFD555Q49667930-A11F7F63-5280-4F4F-AE61-135B08C9E4A7Q50067112-4ACFFC1D-4BE7-454F-84EE-87F20061FFCCQ50083195-77B3AC5A-4CCA-4BD0-B45B-16D780B66A8DQ51736544-BFCEAD6F-F9C8-4C7B-B3C7-60B594EDB3CEQ52646695-88F78BDC-0FC0-4C76-A522-CBA7422B10E5Q55005789-55B6D26C-1856-4D6C-9EAF-1FFF5C327718Q55403266-8794A6C9-37E0-482A-B54C-1769F994A7BFQ57068950-D32B6F1B-F482-44AD-9222-60ECB06400EFQ57295402-3AF50772-6D9A-4516-8DC1-7156A6DBC7AFQ58705828-DDBD1A7D-952C-4013-81D5-F363C4772AFF
P2860
SLC Transporters: Structure, Function, and Drug Discovery.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
SLC Transporters: Structure, Function, and Drug Discovery.
@en
SLC Transporters: Structure, Function, and Drug Discovery.
@nl
type
label
SLC Transporters: Structure, Function, and Drug Discovery.
@en
SLC Transporters: Structure, Function, and Drug Discovery.
@nl
prefLabel
SLC Transporters: Structure, Function, and Drug Discovery.
@en
SLC Transporters: Structure, Function, and Drug Discovery.
@nl
P2860
P356
P1433
P1476
SLC Transporters: Structure, Function, and Drug Discovery
@en
P2093
Avner Schlessinger
P2860
P304
P356
10.1039/C6MD00005C
P577
2016-03-28T00:00:00Z